Factor This Power Engineering
Live Events
DTECH⢠Events
POWERGEN®
Calendar
Resource Center
Webinars
Podcasts
White Papers
Contribute Content
Solar
Utility Scale
Community
Residential
Wind Power
Turbines & Equipment
Offshore
Power Grid
Transmission
Outage Management
Grid Modernization
Smart Grids
Microgrids
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Pumped Storage
Long Duration
Business
Policy & Regulation
Project Development
Finance
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Utility Scale
Community
Residential
Wind Power
Turbines & Equipment
Offshore
Power Grid
Transmission
Outage Management
Grid Modernization
Smart Grids
Microgrids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Pumped Storage
Long Duration
Business
Policy & Regulation
Finance
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Resource Center
Webinars
Podcasts
Whitepapers
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Spruce Biosciences, Inc. - Common Stock
(NQ:
SPRB
)
100.00
-10.00 (-9.09%)
Streaming Delayed Price
Updated: 1:00 PM EST, Nov 28, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Spruce Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Spruce Biosciences Inc (NASDAQ:SPRB) Reports Q3 2025 Results, Secures $50M Financing and Breakthrough Therapy Designation
↗
November 10, 2025
Spruce Biosciences reports Q3 2025 results, secures $50M financing and Breakthrough Therapy Designation for its lead drug candidate.
Via
Chartmill
Spruce Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
November 10, 2025
From
Spruce Biosciences, Inc.
Via
Business Wire
Traders are paying attention to the gapping stocks in Wednesday's session.
↗
October 08, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Wednesday. Let's explore the market movements and identify the stocks with significant gaps.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 08, 2025
Via
Benzinga
SPRB Stock Hits 19-Month High Amid Trading Halts
↗
October 07, 2025
Via
Stocktwits
Spruce Biosciences Stock Nearly Doubles Premarket: 'Pharma Bro' Martin Shkreli Sees 280% Upside
↗
October 07, 2025
Via
Stocktwits
Spruce Biosciences Stock More Than Quadruples After Breakthrough Therapy Designation To Therapy For Rare And Fatal Genetic Disease
↗
October 06, 2025
Via
Stocktwits
Spruce Biosciences Announces $50.0 Million Private Placement Financing
October 08, 2025
From
Spruce Biosciences, Inc.
Via
Business Wire
Top stock movements in today's session.
↗
October 07, 2025
Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
October 07, 2025
Via
Benzinga
Which stocks are moving on Tuesday?
↗
October 07, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Tuesday's session: gap up and gap down stocks
↗
October 07, 2025
The session on Tuesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via
Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
↗
October 07, 2025
Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
October 07, 2025
Via
Benzinga
Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket
↗
October 07, 2025
Via
Benzinga
Spruce Biosciences (SPRB) Stock Jumps 30% After Hours Following Red Hot Rally On Monday: Here's Why
↗
October 07, 2025
Spruce Biosciences shares soared after the FDA granted Breakthrough Therapy Designation to its lead treatment for Sanfilippo Syndrome Type B.
Via
Benzinga
Why Spruce Biosciences Just Skyrocketed More Than 1,600%
↗
October 06, 2025
The company is working on a treatment for a rare, genetic disease.
Via
Investor's Business Daily
Nasdaq Jumps Over 150 Points; Skye Bioscience Shares Plunge
↗
October 06, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
October 06, 2025
Via
Benzinga
Spruce Biosciences Stock Is Soaring Today: Here's Why
↗
October 06, 2025
Shares of Spruce Biosciences, Inc. (NASDAQ: SPRB) are surging Monday after the biotech company shared an important regulatory update about one of its therapy treatments.
Via
Benzinga
US Stocks Mixed; Dow Falls 100 Points
↗
October 06, 2025
Via
Benzinga
Topics
Stocks
Wondering what's happening in today's pre-market session?
↗
October 06, 2025
Discover the top movers in Monday's pre-market session and stay informed about market dynamics.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
October 06, 2025
Via
Benzinga
Spruce Biosciences Receives U.S. FDA Breakthrough Therapy Designation for Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) in Sanfilippo Syndrome Type B (MPS IIIB)
October 06, 2025
From
Spruce Biosciences, Inc.
Via
Business Wire
These stocks that are showing activity before the opening bell on Friday.
↗
October 03, 2025
Wondering what's happening in Friday's pre-market session? Find an overview in this article.
Via
Chartmill
Why Concorde International Group Shares Are Trading Higher By 55%; Here Are 20 Stocks Moving Premarket
↗
October 02, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
September 15, 2025
Via
Benzinga
Spruce Biosciences Resumes Trading on the Nasdaq Capital Market
September 15, 2025
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
August 14, 2025
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences Announces Integrated Long-Term Clinical Data of Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) Demonstrating Profound and Durable Efficacy and Safety in Patients with Sanfilippo Syndrome Type B (MPS IIIB)
August 14, 2025
From
Spruce Biosciences, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
